| Karin E. M. Diderich < Karin Kemsley < Karin Leder | Facettes : |
List of bibliographic references
Number of relevant bibliographic references: 1.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000549 (2012) | John M. Kirkwood [États-Unis] ; Lars Bastholt [Danemark] ; Caroline Robert [France] ; Jeff Sosman [États-Unis] ; James Larkin [Royaume-Uni] ; Peter Hersey [Australie] ; Mark Middleton [Royaume-Uni] ; Mireille Cantarini [Royaume-Uni] ; Victoria Zazulina [Royaume-Uni] ; Karin Kemsley [Royaume-Uni] ; Reinhard Dummer [Suisse] | Phase II, Open-Label, Randomized Trial of the MEK1/2 Inhibitor Selumetinib as Monotherapy versus Temozolomide in Patients with Advanced Melanoma |
List of associated KwdEn.i
| Nombre de documents | Descripteur |
|---|---|
| 1 | Advanced stage |
| 1 | Antineoplastic agent |
| 1 | Clinical trial |
| 1 | Comparative study |
| 1 | Human |
| 1 | Inhibitor |
| 1 | Malignant melanoma |
| 1 | Monotherapy |
| 1 | Patient |
| 1 | Phase II trial |
| 1 | Randomization |
| 1 | Selumetinib |
| 1 | Temozolomide |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Karin Kemsley"
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i \
-Sk "Karin Kemsley" \
| HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= France
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Karin Kemsley
}}
| This area was generated with Dilib version V0.6.38. |  |